Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 1 (January)

1. Identification and characterization of hepsin/-TM, a non-transmembrane hepsin isoform.
   Biochim Biophys Acta, 1681(2): 157-65. [Abstract] [Full-text]
2. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols.
   Int J Radiat Oncol Biol Phys, 61(1): 92-102. [Abstract] [Full-text]
3. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma.
   Int J Radiat Oncol Biol Phys, 61(1): 85-91. [Abstract] [Full-text]
4. Protein expression of Mdm2 and p53 in hyperplastic and neoplastic lesions of the canine circumanal gland.
   J Comp Pathol, 132(1): 27-32. [Abstract] [Full-text]
5. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.
   Mod Pathol, 18(1): 19-25. [Abstract] [Full-text]
6. Magnesium intake in relation to risk of colorectal cancer in women.
   JAMA, 293(1): 86-9. [Abstract] [Full-text]
7. Metastatic lymph node size and colorectal cancer prognosis.
   J Am Coll Surg, 200(1): 20-8. [Abstract] [Full-text]
8. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance.
   Blood, 105(2): 721-7. [Abstract] [Full-text]
9. Colorectal cancer prevention.
   J Clin Oncol, 23(2): 378-91. [Abstract] [Full-text]
10. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.
    Oncogene, 24(1): 118-29. [Abstract] [Full-text]
11. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein.
    Oncogene, 24(1): 148-56. [Abstract] [Full-text]
12. Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.
    Jpn J Clin Oncol, 34(12): 740-6. [Abstract] [Full-text]
13. Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis.
    Cancer Lett, 218(1): 33-41. [Abstract] [Full-text]
14. Colorectal cancer.
    Lancet, 365(9454): 153-65. [Abstract] [Full-text]
15. Physician recommendations for follow-up of positive fecal occult blood tests.
    Med Care Res Rev, 62(1): 79-110. [Abstract] [Full-text]
16. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.
    Nucleic Acids Res, 33(1): 106-13. [Abstract] [Full-text]
17. Detection of disseminated tumour cells in the liver of colorectal cancer patients.
    Eur J Surg Oncol, 31(1): 38-44. [Abstract] [Full-text]
18. Surgical trauma and peritoneal recurrence of colorectal carcinoma.
    Eur J Surg Oncol, 31(1): 29-37. [Abstract] [Full-text]
19. The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study.
    Eur J Surg Oncol, 31(1): 22-8. [Abstract] [Full-text]
20. Recent developments in CT colonography.
    Clin Radiol, 60(1): 1-7. [Abstract] [Full-text]
21. Modifying effect of propolis on dimethylhydrazine-induced DNA damage but not colonic aberrant crypt foci in rats.
    Environ Mol Mutagen, 45(1): 8-16. [Abstract] [Full-text]
22. Laparoscopic restorative proctocolectomy.
    Br J Surg, 92(1): 88-93. [Abstract] [Full-text]
23. Emergency surgery for colonic cancer in a defined population.
    Br J Surg, 92(1): 94-100. [Abstract] [Full-text]
24. Meat consumption and risk of colorectal cancer.
    JAMA, 293(2): 172-82. [Abstract] [Full-text]
25. Increased use of low anterior resection for veterans with rectal cancer.
    Aliment Pharmacol Ther, 21(1): 35-41. [Abstract] [Full-text]
26. Metastatic colon carcinoma found within an enterocele sac: a case report.
    Int Urogynecol J Pelvic Floor Dysfunct, 16(1): 73-4. [Abstract] [Full-text]
27. Added value of CT colonography after a positive conventional colonoscopy: impact on treatment strategy.
    Abdom Imaging, 30(1): 42-7. [Abstract] [Full-text]
28. Colorectal cancer screening and surveillance with CT colonography: current controversies and obstacles.
    Abdom Imaging, 30(1): 5-12. [Abstract] [Full-text]
29. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery.
    Gut, 54(2): 268-73. [Abstract] [Full-text]
30. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Gut, 54(2): 264-7. [Abstract] [Full-text]
31. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
    J Cell Biochem, 94(2): 336-50. [Abstract] [Full-text]
32. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer.
    Cancer Immunol Immunother, 54(3): 265-72. [Abstract] [Full-text]
33. Irreversible lower limb ischaemia following ligation of the inferior mesenteric artery in the surgical treatment of rectal cancer.
    Tech Coloproctol, 8(3): 183-4. [Abstract] [Full-text]
34. High-magnification chromoscopic pouchoscopy: a novel in vivo technique for surveillance of the anal transition zone and columnar cuff following ileal pouch-anal anastomosis.
    Tech Coloproctol, 8(3): 173-8; discussion 178. [Abstract] [Full-text]
35. Which colorectal cancers are missed by double contrast barium enema?
    Tech Coloproctol, 8(3): 169-72. [Abstract] [Full-text]
36. Screening for colorectal cancer: implications for UK and European initiatives.
    Tech Coloproctol, 8(3): 139-45. [Abstract] [Full-text]
37. Impaired activation of caspases and prevention of mitochondrial dysfunction in the metastatic colon carcinoma CC531s-m2 cell line.
    Biochem Pharmacol, 69(3): 463-71. [Abstract] [Full-text]
38. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
    BMC Cancer, 4(1): 92. [Abstract] [Full-text]
39. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication.
    BMC Public Health, 4(1): 62. [Abstract] [Full-text]
40. Application of adjuvant chemotherapy in colorectal cancer -- a survey in the region of Essen, Germany.
    Onkologie, 28(1): 7-10. [Abstract] [Full-text]
41. Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.
    J Gene Med, 7(1): 39-49. [Abstract] [Full-text]
42. Synchronous and metachronous colorectal carcinoma.
    Tech Coloproctol, 8: s97-s100. [Abstract] [Full-text]
43. Use of intraluminal stapler device for creation of a permanent colostomy.
    Tech Coloproctol, 8: s93-6. [Abstract] [Full-text]
44. Is TNM classification related to early postoperative morbidity and mortality after colorectal cancer resections?
    Tech Coloproctol, 8: s89-92. [Abstract] [Full-text]
45. Pelvic reconstruction of the retroperitoneum after abdominoperineal resection of the rectum using full-thickness skin grafts.
    Tech Coloproctol, 8: s85-8. [Abstract] [Full-text]
46. Surgical management of large bowel obstruction due to colonic cancer.
    Tech Coloproctol, 8: s82-4. [Abstract] [Full-text]
47. Anastomotic leakage following anterior resection for rectal cancer.
    Tech Coloproctol, 8: s79-81. [Abstract] [Full-text]
48. Electrocoagulation: an alternative palliative treatment for rectal cancer.
    Tech Coloproctol, 8: s76-8. [Abstract] [Full-text]
49. Synchronous polyps in patients with colorectal cancer.
    Tech Coloproctol, 8: s72-5. [Abstract] [Full-text]
50. Environmental and other risk factors for colorectal carcinogenesis.
    Tech Coloproctol, 8: s7-9. [Abstract] [Full-text]
51. Management of colorectal cancer: 20 years' experience.
    Tech Coloproctol, 8: s68-71. [Abstract] [Full-text]
52. Serum concentrations of soluble ICAM-1 and VCAM-1 in patients with colorectal cancer. Clinical implications.
    Tech Coloproctol, 8: s65-7. [Abstract] [Full-text]
53. Anaemia as a symptom of right colon cancer.
    Tech Coloproctol, 8: s62-4. [Abstract] [Full-text]
54. The effect of aspirin and high fibre diet on colorectal carcinoma: a comparative experimental study.
    Tech Coloproctol, 8: s59-61. [Abstract] [Full-text]
55. Serum levels of bcl-2 in patients with colorectal cancer.
    Tech Coloproctol, 8: s56-8. [Abstract] [Full-text]
56. The failed intraperitoneal colon anastomosis after colon resection.
    Tech Coloproctol, 8: s53-5. [Abstract] [Full-text]
57. Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer.
    Tech Coloproctol, 8: s50-2. [Abstract] [Full-text]
58. Chemotherapy in metastatic colorectal cancer.
    Tech Coloproctol, 8: s43-6. [Abstract] [Full-text]
59. The management of peritoneal surface malignancy of colorectal cancer origin.
    Tech Coloproctol, 8: s39-42. [Abstract] [Full-text]
60. Five fractions of preoperative radiotherapy for selected cases of rectal cancer.
    Tech Coloproctol, 8: s36-8. [Abstract] [Full-text]
61. The surgical approach to locally recurrent rectal cancer.
    Tech Coloproctol, 8: s33-5. [Abstract] [Full-text]
62. Colon cancer: resection standards.
    Tech Coloproctol, 8: s29-32. [Abstract] [Full-text]
63. Complications in laparoscopic colorectal surgery: results of a multicentre trial.
    Tech Coloproctol, 8: s25-8. [Abstract] [Full-text]
64. Emergency operations for carcinoma of the colon.
    Tech Coloproctol, 8: s235-7. [Abstract] [Full-text]
65. Perineal wound closure after abdomino-perineal excision of the rectum.
    Tech Coloproctol, 8: s230-4. [Abstract] [Full-text]
66. Emergency operation in carcinomas of the left colon: value of Hartmann's procedure.
    Tech Coloproctol, 8: s226-9. [Abstract] [Full-text]
67. Results of laparoscopic treatment of rectal cancer: analysis of 520 patients.
    Tech Coloproctol, 8: s22-4. [Abstract] [Full-text]
68. Total mesorectal excision with the water-jet-dissection. Technique and results.
    Tech Coloproctol, 8: s217-25. [Abstract] [Full-text]
69. Oophorectomy during surgery for colorectal carcinoma.
    Tech Coloproctol, 8: s214-6. [Abstract] [Full-text]
70. The presence and significance of iron in neoplasia of the colorectum.
    Tech Coloproctol, 8: s211-3. [Abstract] [Full-text]
71. Colorectal carcinoma: contribution of growth pattern on prognosis.
    Tech Coloproctol, 8: s208-10. [Abstract] [Full-text]
72. Manometric and clinical evaluation of patients after low anterior resection for rectal cancer.
    Tech Coloproctol, 8: s205-7. [Abstract] [Full-text]
73. Metachronous colorectal adenocarcinomas.
    Tech Coloproctol, 8: s202-4. [Abstract] [Full-text]
74. Treatment of complicated colorectal cancer. Evaluation of the outcome.
    Tech Coloproctol, 8: s199-201. [Abstract] [Full-text]
75. Stage of disease at time of attendance of patients with colorectal cancer at the Department of Surgery of the General Hospital of Edessa.
    Tech Coloproctol, 8: s196-8. [Abstract] [Full-text]
76. Mass screening for colorectal cancer: compliance in Almopea Region.
    Tech Coloproctol, 8: s193-5. [Abstract] [Full-text]
77. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers.
    Tech Coloproctol, 8: s190-2. [Abstract] [Full-text]
78. Priority of resection in concomitant abdominal aortic aneurysm (AAA) and colorectal cancer (CRC): review of the literature and experience of our clinic.
    Tech Coloproctol, 8: s19-21. [Abstract] [Full-text]
79. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
    Tech Coloproctol, 8: s187-9. [Abstract] [Full-text]
80. Application of radionics on primary and metastatic tumours of the liver.
    Tech Coloproctol, 8: s184-6. [Abstract] [Full-text]
81. Synchronous colorectal cancer.
    Tech Coloproctol, 8: s177-9. [Abstract] [Full-text]
82. Current treatment of colorectal liver metastases.
    Tech Coloproctol, 8: s174-6. [Abstract] [Full-text]
83. Assessment of local stage in rectal cancer using endorectal ultrasonography (EUS).
    Tech Coloproctol, 8: s170-3. [Abstract] [Full-text]
84. Survival after curative resection for rectal cancer by the end of the 20th century.
    Tech Coloproctol, 8: s167-9. [Abstract] [Full-text]
85. Carcinoid: modern aspects on its therapy.
    Tech Coloproctol, 8: s164-6. [Abstract] [Full-text]
86. Obesity and colorectal cancer.
    Tech Coloproctol, 8: s161-3. [Abstract] [Full-text]
87. Magnetic resonance imaging in rectal cancer: the MERCURY experience.
    Tech Coloproctol, 8: s16-8. [Abstract] [Full-text]
88. Repair of parastomal hernia with the use of polypropylene mesh extraperitoneally.
    Tech Coloproctol, 8: s158-60. [Abstract] [Full-text]
89. Colorectal gastrointestinal mesenchymal tumours. Report of a stromal case of the rectum (GIST) and a leiomyosarcoma of the transverse colon.
    Tech Coloproctol, 8: s155-7. [Abstract] [Full-text]
90. Five-year survival after curative resection for adenocarcinoma of the colon.
    Tech Coloproctol, 8: s152-4. [Abstract] [Full-text]
91. Adjuvant chemotherapy in colorectal cancer.
    Tech Coloproctol, 8: s149-51. [Abstract] [Full-text]
92. Are there any differences in colorectal cancer between young and elderly patients?
    Tech Coloproctol, 8: s147-8. [Abstract] [Full-text]
93. Age-associated prognosis following curative resection for colorectal cancer.
    Tech Coloproctol, 8: s144-6. [Abstract] [Full-text]
94. Accuracy of endorectal ultrasonography in the preoperative staging of rectal cancer.
    Tech Coloproctol, 8: s14-5. [Abstract] [Full-text]
95. A case of mucinous adenocarcinoma arising in long-standing multiple perianal and presacral fistulas.
    Tech Coloproctol, 8: s138-40. [Abstract] [Full-text]
96. Metastatic breast adenocarcinoma masquerading as colonic primary. Report of two cases.
    Tech Coloproctol, 8: s135-7. [Abstract] [Full-text]
97. Locally recurrent rectal cancer after curative resection.
    Tech Coloproctol, 8: s132-4. [Abstract] [Full-text]
98. Metachronous breast carcinoma (second malignancy), following "cure" from colorectal carcinoma.
    Tech Coloproctol, 8: s129-31. [Abstract] [Full-text]
99. Prognostic significance of mucinous component in colorectal carcinoma.
    Tech Coloproctol, 8: s123-5. [Abstract] [Full-text]
100. Radio-frequency ablation of hepatic metastases from colorectal cancer.
     Tech Coloproctol, 8: s119-22. [Abstract] [Full-text]
101. Colorectal cancer in patients over 70 years of age: determinants of outcome.
     Tech Coloproctol, 8: s112-5. [Abstract] [Full-text]
102. Abdominal wall metastasis following treatment of rectal cancer.
     Tech Coloproctol, 8: s101-3. [Abstract] [Full-text]
103. Screening for colorectal cancer.
     Tech Coloproctol, 8: s10-3. [Abstract] [Full-text]
104. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
     Am J Gastroenterol, 100(1): 139-43. [Abstract] [Full-text]
105. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
     Am J Gastroenterol, 100(1): 130-8. [Abstract] [Full-text]
106. Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.
     Am J Gastroenterol, 100(1): 27-37. [Abstract] [Full-text]
107. Angiosarcoma of the colon and rectum: report of a case and review of the literature.
     Dis Colon Rectum, 47(12): 2202-7. [Abstract] [Full-text]
108. Improvement of colonic healing by preoperative rectal irrigation with short-chain fatty acids in rats given radiotherapy.
     Dis Colon Rectum, 47(12): 2184-94. [Abstract] [Full-text]
109. Distilled water peritoneal lavage after colorectal cancer surgery.
     Dis Colon Rectum, 47(12): 2114-9. [Abstract] [Full-text]
110. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
     Dis Colon Rectum, 47(12): 2105-13. [Abstract] [Full-text]
111. Hyperplastic polyposis and the risk of colorectal cancer.
     Dis Colon Rectum, 47(12): 2101-4. [Abstract] [Full-text]
112. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
     Dis Colon Rectum, 47(12): 2093-100. [Abstract] [Full-text]
113. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer.
     Dis Colon Rectum, 47(12): 2086-91; discussion 2091-2. [Abstract] [Full-text]
114. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival.
     Dis Colon Rectum, 47(12): 2076-9. [Abstract] [Full-text]
115. Review of survival curves for colorectal cancer.
     Dis Colon Rectum, 47(12): 2070-5. [Abstract] [Full-text]
116. Are survival rates different for young and older patients with rectal cancer?
     Dis Colon Rectum, 47(12): 2064-9. [Abstract] [Full-text]
117. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.
     Dis Colon Rectum, 47(12): 2055-63. [Abstract] [Full-text]
118. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis.
     Dis Colon Rectum, 47(12): 2047-53; discussion 2053-4. [Abstract] [Full-text]
119. Outcome of salvage abdominoperineal resection after failed endocavitary radiation in patients with rectal cancer.
     Dis Colon Rectum, 47(12): 2039-46. [Abstract] [Full-text]
120. The efficacy of a nerve stimulator (CaverMap) to enhance autonomic nerve identification and confirm nerve preservation during total mesorectal excision.
     Dis Colon Rectum, 47(12): 2032-8. [Abstract] [Full-text]
121. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
     Dis Colon Rectum, 47(12): 2025-31. [Abstract] [Full-text]
122. Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model.
     Dis Colon Rectum, 47(12): 2015-24. [Abstract] [Full-text]
123. Lung adenocarcinoma associated with familial adenomatous polyposis. Clear cell carcinoma with beta-catenin accumulation accompanied by atypical adenomatous hyperplasia.
     Virchows Arch, 446(1): 73-7. [Abstract] [Full-text]
124. Repetitive treatments of colon HT-29 cells with diallyl disulfide induce a prolonged hyperacetylation of histone H3 K14.
     Ann N Y Acad Sci, 1030: 612-21. [Abstract] [Full-text]
125. Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer.
     Ann N Y Acad Sci, 1030: 377-83. [Abstract] [Full-text]
126. Systematic review of microsatellite instability and colorectal cancer prognosis.
     J Clin Oncol, 23(3): 609-18. [Abstract] [Full-text]
127. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
     J Clin Oncol, 23(3): 502-9. [Abstract] [Full-text]
128. Restoring mismatch repair does not stop the formation of reciprocal translocations in the colon cancer cell line HCA7 but further destabilizes chromosome number.
     Oncogene, 24(4): 706-13. [Abstract] [Full-text]
129. Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia.
     Oncogene, 24(4): 724-31. [Abstract] [Full-text]
130. beta-Catenin activates the growth factor endothelin-1 in colon cancer cells.
     Oncogene, 24(4): 597-604. [Abstract] [Full-text]
131. Body mass index and the risk of male cancer mortality of various sites: 17-year follow-up of the Basel cohort study.
     Swiss Med Wkly, 135(1): 27-33. [Abstract] [Full-text]
132. Insight into the functional consequences of hMYH variants associated with colorectal cancer: distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH.
     DNA Repair (Amst), 4(3): 315-25. [Abstract] [Full-text]
133. A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
     Crit Rev Oncol Hematol, 53(2): 133-9. [Abstract] [Full-text]
134. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
     Eur J Cancer, 41(2): 272-9. [Abstract] [Full-text]
135. Renal papillae metastasis of sigmoid colon adenocarcinoma.
     Int J Urol, 12(1): 93-5. [Abstract] [Full-text]
136. Inherited susceptibility to colorectal cancer.
     Annu Rev Med, 56: 539-54. [Abstract] [Full-text]
137. 5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells.
     J Cancer Res Clin Oncol, 131(3): 184-90. [Abstract] [Full-text]
138. Automated mass detection in contrast-enhanced CT colonography: an approach based on contrast and volume.
     Eur Radiol, 15(2): 247-53. [Abstract] [Full-text]
139. Familial adenomatous polyposis. Surgical treatment: when and how.
     Tech Coloproctol, 8: s309-14. [Abstract] [Full-text]
140. Familial adenomatous polyposis: genetics and epidemiology.
     Tech Coloproctol, 8: s305-8. [Abstract] [Full-text]
141. Local excision of rectal polyp: indications and techniques.
     Tech Coloproctol, 8: s300-4. [Abstract] [Full-text]
142. Locating polyps by endoscopy with or without videolaparoscopy, radioguided occult colonic lesion identification or magnetic endoscopic imaging: the way forward to complete polyp removal.
     Tech Coloproctol, 8: s295-9. [Abstract] [Full-text]
143. Indications for colorectal resection for adenoma before and after polypectomy.
     Tech Coloproctol, 8: s291-4. [Abstract] [Full-text]
144. Endoscopic polypectomy: techniques, complications and follow-up.
     Tech Coloproctol, 8: s283-90. [Abstract] [Full-text]
145. Advanced diagnostic tools: virtual colonoscopy and magnifying chromoendoscopy.
     Tech Coloproctol, 8: s279-82. [Abstract] [Full-text]
146. Advanced diagnostic tools: virtual colonoscopy.
     Tech Coloproctol, 8: s276-8. [Abstract] [Full-text]
147. Sensitivity of diagnostic examinations for colorectal polyps.
     Tech Coloproctol, 8: s273-5. [Abstract] [Full-text]
148. Colorectal carcinoma: is screening possible?
     Tech Coloproctol, 8: s267-72. [Abstract] [Full-text]
149. Flat colorectal neoplasms: endoscopic detection, clinical relevance and management.
     Tech Coloproctol, 8: s261-6. [Abstract] [Full-text]
150. Colonic neoplastic polyps: biopsy is not efficient to exclude malignancy. The Trafford experience.
     Tech Coloproctol, 8: s257-60. [Abstract] [Full-text]
151. Malignant adenoma: diagnosis, staging, risk factors, lymph node involvement and problems of sampling.
     Tech Coloproctol, 8: s253-6. [Abstract] [Full-text]
152. Chemoprevention of colorectal cancer: an update.
     Tech Coloproctol, 8: s248-52. [Abstract] [Full-text]
153. Epidemiology of colorectal polyps.
     Tech Coloproctol, 8: s243-7. [Abstract] [Full-text]
154. Genetics of colorectal polyps.
     Tech Coloproctol, 8: s240-2. [Abstract] [Full-text]
155. Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer.
     Eur J Radiol, 53(2): 256-62. [Abstract] [Full-text]
156. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison.
     Lancet, 365(9456): 305-11. [Abstract] [Full-text]
157. Behavioral associations between prostate and colon cancer screening.
     J Am Coll Surg, 200(2): 216-23. [Abstract] [Full-text]
158. Synchronous anal and penile cancers.
     Int J Urol, 11(12): 1139-41. [Abstract] [Full-text]
159. Plasma prolactin in patients with colorectal cancer.
     BMC Cancer, 4(1): 97. [Abstract] [Full-text]
160. Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
     Carcinogenesis, 26(2): 353-7. [Abstract] [Full-text]
161. Green vegetables, red meat and colon cancer: chlorophyll prevents the cytotoxic and hyperproliferative effects of haem in rat colon.
     Carcinogenesis, 26(2): 387-93. [Abstract] [Full-text]
162. Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population.
     Carcinogenesis, 26(2): 411-6. [Abstract] [Full-text]
163. Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.
     Hum Pathol, 35(11): 1427-30. [Abstract] [Full-text]
164. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer.
     Hum Pathol, 35(11): 1392-6. [Abstract] [Full-text]
165. A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity.
     Ann Oncol, 16(2): 282-8. [Abstract] [Full-text]
166. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.
     Ann Oncol, 16(2): 189-94. [Abstract] [Full-text]
167. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis.
     Int J Radiat Oncol Biol Phys, 61(2): 426-31. [Abstract] [Full-text]
168. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
     Chin J Dig Dis, 6(1): 26-30. [Abstract] [Full-text]
169. Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116.
     Chin J Dig Dis, 6(1): 15-20. [Abstract] [Full-text]
170. Low expression of XIAP-associated factor 1 in human colorectal cancers.
     Chin J Dig Dis, 6(1): 10-4. [Abstract] [Full-text]
171. Calcium supplements to prevent colorectal adenomas.
     Am J Gastroenterol, 100(2): 395-6. [Abstract] [Full-text]
172. Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials.
     Am J Gastroenterol, 100(2): 390-4. [Abstract] [Full-text]
173. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
     Gene Ther, 12(3): 272-80. [Abstract] [Full-text]
174. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
     Biochem Biophys Res Commun, 328(1): 227-34. [Abstract] [Full-text]
175. Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.
     FEBS J, 272(3): 696-710. [Abstract] [Full-text]
176. Genotype phenotype correlations in Israeli colorectal cancer patients.
     Int J Cancer, 114(1): 58-73. [Abstract] [Full-text]
177. Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.
     Int J Cancer, 114(1): 80-7. [Abstract] [Full-text]
178. Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.
     J Cancer Res Clin Oncol, 131(2): 101-10. [Abstract] [Full-text]
179. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
180. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
     Surg Today, 35(2): 131-8. [Abstract] [Full-text]
181. Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.
     Surgery, 137(2): 246-9. [Abstract] [Full-text]
182. Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion.
     Surgery, 137(2): 156-64. [Abstract] [Full-text]
183. Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis.
     Nucleic Acids Res, 33(2): 597-604. [Abstract] [Full-text]
184. Osseous metaplasia in a tubular adenoma of the colon.
     J Clin Pathol, 58(2): 220-1. [Abstract] [Full-text]
185. Perianal apocrine adenocarcinoma arising in a benign apocrine adenoma; first case report and review of the literature.
     J Clin Pathol, 58(2): 217-9. [Abstract] [Full-text]
186. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability.
     Cancer Genet Cytogenet, 157(1): 18-24. [Abstract] [Full-text]
187. Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis.
     Jpn J Clin Oncol, 35(1): 18-22. [Abstract] [Full-text]
188. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
     Mutat Res, 570(1): 89-96. [Abstract] [Full-text]
189. A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non-polyposis colorectal cancer.
     Clin Genet, 67(2): 178-82. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.